These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1288507)

  • 21. Acute antihypertensive effect of nifedipine by sublingual route in cases with clinically severe systolic hypertension. A study up to 4 h after administration.
    Ito H; Arakawa M; Shibasaki T; Hirakawa S; Fukuda T; Yasue T; Kondo Y; Watanabe I; Mori N; Fueki T
    Arzneimittelforschung; 1984; 34(5):630-6. PubMed ID: 6380506
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lisinopril versus slow-release nifedipine in the treatment of mild to moderate hypertension: a multicentre study. The Cooperative Study Group.
    Witchitz S; Serradimigni A
    J Hum Hypertens; 1989 Jun; 3 Suppl 1():29-33. PubMed ID: 2550643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Double-blind, placebo-controlled trial of twice-daily nifedipine as a step-2 agent in mild essential hypertension.
    Svetkey LP; Weinberger MH; Gavras H; Gavras I; Brown TS; Deterding J; Klotman PE
    J Clin Hypertens; 1987 Dec; 3(4):579-88. PubMed ID: 3330988
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential effects of once-daily antihypertensive drugs on blood pressure, left ventricular mass and sympathetic activity: Nifedipine-GITS versus felodipine-ER versus enalapril.
    Leenen FH; Myers MG; Joyner CD; Toal CB
    Can J Cardiol; 2002 Dec; 18(12):1285-93. PubMed ID: 12518180
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Double-blind comparison between nifedipine and amlodipine for the treatment of essential hypertension.
    Cappuccio FP; Markandu ND; Singer DR; Crane M; Carney C; MacGregor GA
    J Hum Hypertens; 1993 Aug; 7(4):365-8. PubMed ID: 8410927
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Double-blind crossover study of once daily nifedipine coat core in essential hypertension.
    Missouris CG; Cappuccio FP; Markandu ND; Singer DR; MacGregor GA
    J Hum Hypertens; 1994 Apr; 8(4):289-92. PubMed ID: 8021910
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparative study to assess the efficacy and adverse effects of amlodipine and nifedipine retard in patients with stable exertional angina and hypertension].
    Witkowska M; Tracz W; Kubler G; Negrusz-Kawecka M; Hlawaty M; Olszowska M; Salamon P
    Przegl Lek; 1997; 54(5):324-8. PubMed ID: 9380807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute and chronic hypotensive effects of nifedipine and niludipine in hypertensive patients with chronic renal failure.
    Kusano E; Asano Y; Takeda K; Terao N; Hosoda S
    Arzneimittelforschung; 1984; 34(5):624-9. PubMed ID: 6432001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antihypertensive effects of long-acting calcium channel blockers on hemodialysis days--a randomized crossover trial between benidipine and nifedipine CR.
    Kojima M; Taniguchi M; Sato K; Ueda R; Dohi Y
    Nephron Clin Pract; 2004; 97(2):c49-53. PubMed ID: 15218330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative pharmacokinetics and antihypertensive effects of the nifedipine tablet and capsule.
    Myers MG; Raemsch KD
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S76-8. PubMed ID: 2455148
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral slow-release nifedipine in the rapid treatment of severe hypertension in Nigerians.
    Arije A; Omotoso AB; Erasmus RT
    West Afr J Med; 1994; 13(2):116-20. PubMed ID: 7803325
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Controlled release nifedipine and valsartan combination therapy in patients with essential hypertension: the adalat CR and valsartan cost-effectiveness combination (ADVANCE-combi) study.
    Saito I; Saruta T;
    Hypertens Res; 2006 Oct; 29(10):789-96. PubMed ID: 17283866
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Slow-release nifedipine: effect on the circadian rhythm of blood pressure in essential hypertension.
    Portaluppi F; degli Uberti E; Strozzi C; Margutti A; Montanari L; Rambaldi R; Trasforini G; Pansini R
    Acta Cardiol; 1987; 42(1):37-47. PubMed ID: 3494367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antihypertensive effect of nifedipine and its relationship to severity of hypertension.
    Yoshimura M; Takashina R; Shikuma R; Takahashi H; Takeda K; Ashizawa H; Ochi Y; Ijichi H
    Arzneimittelforschung; 1983; 33(2):254-7. PubMed ID: 6682666
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of once-daily nifedipine controlled-release with twice-daily nifedipine retard in the treatment of essential hypertension.
    Minami J; Numabe A; Andoh N; Kobayashi N; Horinaka S; Ishimitsu T; Matsuoka H
    Br J Clin Pharmacol; 2004 May; 57(5):632-9. PubMed ID: 15089817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Evaluation of the antihypertensive effect of capsule and tablet forms of nifedipine in moderate hypertension].
    Thibonnier M; Sassano P; Corvol P
    Arch Mal Coeur Vaiss; 1985 Nov; 78 Spec No():25-8. PubMed ID: 3937501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nifedipine and atenolol singly and combined for treatment of essential hypertension: comparative multicentre study in general practice in the United Kingdom. Nifedipine-Atenolol Study Review Committee.
    Nifedipine-Atenolol Study Review Committee
    Br Med J (Clin Res Ed); 1988 Feb; 296(6620):468-72. PubMed ID: 2894883
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
    Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential effects of felodipine and nifedipine on 24-h blood pressure and left ventricular mass.
    Myers MG; Leenen FH; Tanner J
    Am J Hypertens; 1995 Jul; 8(7):712-8. PubMed ID: 7546497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conversion from sustained-release to immediate-release calcium entry blockers: outcome in patients with mild-to-moderate hypertension.
    Hilleman DE; Mohiuddin SM; Lucas BD; Shinn B; Elsasser GN
    Clin Ther; 1993; 15(6):1002-10. PubMed ID: 8111798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.